334 results on '"Gasche, C."'
Search Results
2. Increased expression of HIF2α during iron deficiency–associated megakaryocytic differentiation
3. RUMINOCOCCUS GNAVUS 3β-HSDH LINKS MUCOSAL BIOFILMS AND BILE ACID MALABSORPTION
4. Loss of Nrf2 decreases tumorigenesis in a mouse model of Lynch Syndrome and is associated with an increase in bacterial diversity
5. Chemoprävention des kolitisassoziierten kolorektalen Karzinoms mit Mesalazin
6. P511 Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01)
7. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
8. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases:an International Organization for Study of Inflammatory Bowel Diseases consensus
9. The IL-10R1 S138G loss-of-function allele and ulcerative colitis
10. Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells
11. Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease
12. Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection
13. European evidence based consensus on the diagnsis and management of Crohn's disease: definitions and diagnosis
14. Genotypes and phenotypes in Crohn's disease: do they help in clinical management?
15. Iron, Anaemia and Inflammatory Bowel Diseases
16. A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis
17. Subgroups of Crohn’s disease — are there therapeutic differences?
18. Cancer in inflammatory bowel disease: is there a chance for cancer prevention?
19. Treatment of Crohn's disease with recombinant human interleukin 10 induces the Proinflammatory cytokine interferon γ. (Inflammation and Inflammatory Bowel Disease)
20. An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation
21. Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine
22. In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis
23. IL-10 RECEPTOR 1: ASSOCIATION STUDY IN MAJOR DEPRESSION
24. Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?
25. Systematic review: managing anaemia in Crohnʼs disease
26. IL-10 RECEPTOR 1: ASSOCIATION STUDY IN MAJOR DEPRESSION
27. INFECTION, INFLAMMATION, AND GASTROINTESTINAL CANCER
28. Value of MR colonography for assessment of inflammatory bowel disease? Believe what you see—see what you believe
29. the chemoprevention of colorectal carcinoma
30. Believe in Iron
31. IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases
32. Ultrasonographic findings in Crohnʼs disease
33. Intestinal Biofilms are an endoscopic Feature of Irretable Bowel Syndrome
34. The food additive EDTA increases intestinal inflammation and colorectal carcinogenesis by disrupting the intestinal epithelial barrier
35. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease
36. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease
37. Safety, tolerance and activity of multiple doses of subcutaneous recombinant human interleukin-10 (rHuIL-10) in patients with mild to moderate active Crohn's disease 11.02
38. Steroid dependency in Crohn's disease
39. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis
40. PWE-013 The effects of iron therapy on iron transport in human colorectal cancer
41. PWE-014 Iron therapy and its effect on cell proliferation in human colorectal carcinoma
42. Iron deficiency workup reveals high incidence of autoimmune gastritis with parietal cell antibody as reliable screening test
43. Iron therapy reduces platelet activity in patients with elevated platelet levels, iron deficiency and IBD. The randomized, controlled, sinlge-blind ThromboACT trial
44. EDTA compounds, used for food stabilizing agents, aggravate inflammation and drive tumorigenesis in a mouse model of colitis-associated carcinogenesis
45. Looking beyond symptoms and disease activity to define disease severity in inflammatory bowel disease: results of an IOIBD specialist panel
46. A novel PAK1/Notch-1 axis contributes to intestinal inflammation and cancer
47. Bacterial translocation into the mucus of crypts is associated with proximal colonic tumorigenesis in IL-10-/-xMSH2loxP/loxP Vill-cre (DKO) mice
48. CURRENT PRACTICE OF ANAEMIA MANAGEMENT IN PATIENTS WITH IBD ACROSS NINE EUROPEAN COUNTRIES
49. On the safety of intravenous iron, evidence trumps conjecture
50. Autoimmune gastritis is common in patients with iron deficiency – Non-invasive evaluation of iron deficiency aside guideline recommendations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.